Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference25 articles.
1. Jones GH, Carrier MA, Silver RT, Kantarjian H. Strategies that delay or prevent the timely availability of affordable generic drugs in the United States. Blood. 2016;127(11):1398–402. https://doi.org/10.1182/blood-2015-11-680058.
2. Yu LX, Amidon G, Khan MA, Hoag SW, Polli J, Raju GK, et al. Understanding pharmaceutical quality by design. AAPS J. 2014;16(4):771–83. https://doi.org/10.1208/s12248-014-9598-3.
3. Sakore S, Chakraborty BS. In vitro-in vivo correlation (IVIVC): a strategic tool in drug development. J Bioequiv Bioavailab. 2011. https://doi.org/10.4172/jbb.S3-001.
4. Amidon GL, Lennernäs H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 1995;12(3):413–20. https://doi.org/10.1023/a:1016212804288.
5. Tanguay M, Potvin D, Haddad J, Lavigne J, MJ F, D M, et al. When will a drug formulation pass or fail bioequivalence criteria? Experience from 1200 studies. AAPS PharmSciTech. 2002;4(4):Abstract R6193.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献